↓ Skip to main content

Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D)

Overview of attention for article published in BMC Cancer, October 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (68th percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
74 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D)
Published in
BMC Cancer, October 2014
DOI 10.1186/1471-2407-14-780
Pubmed ID
Authors

Robyn PM Saw, Bruce K Armstrong, Rebecca S Mason, Rachael L Morton, Kerwin F Shannon, Andrew J Spillane, Jonathan R Stretch, John F Thompson

Abstract

Patients with primary cutaneous melanomas that are ulcerated and >2 mm in thickness, >4 mm in thickness and those with nodal micrometastases at diagnosis, have few options for adjuvant treatment. Recent studies have suggested a role for vitamin D to delay melanoma recurrence and improve overall prognosis.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 74 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
France 1 1%
Unknown 73 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 16 22%
Student > Bachelor 11 15%
Researcher 10 14%
Student > Ph. D. Student 5 7%
Professor > Associate Professor 4 5%
Other 15 20%
Unknown 13 18%
Readers by discipline Count As %
Medicine and Dentistry 32 43%
Agricultural and Biological Sciences 7 9%
Biochemistry, Genetics and Molecular Biology 5 7%
Nursing and Health Professions 2 3%
Computer Science 2 3%
Other 12 16%
Unknown 14 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 November 2014.
All research outputs
#7,136,697
of 22,768,097 outputs
Outputs from BMC Cancer
#1,919
of 8,279 outputs
Outputs of similar age
#80,350
of 260,971 outputs
Outputs of similar age from BMC Cancer
#37
of 179 outputs
Altmetric has tracked 22,768,097 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 8,279 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 260,971 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 179 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.